Table of Contents
1 Introduction
1.1 Definition
1.2 Scope of Study
1.3 Research Objective
1.4 Assumptions & Limitations
1.5 Market Structure:
2 Research Methodology
2.1 Research Process
2.2 Primary Research
2.3 Secondary Research
3 Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
3.5 Macroeconomic Indicators
4 Market Factor Analysis
4.1 Porter’s Five Forces Model
4.1.1 Bargaining Power of Suppliers
4.1.2 Bargaining Power of Customer
4.1.3 Intensity of Competitor’s
4.1.4 Threat of New Entrants
5 Global Hospital Acquired Infections Market, by Pathogen Types
5.1 Introduction
5.1.1 Viral
5.1.2 Bacterial
5.1.3 Fungal
6 Global Hospital Acquired Infections Market, by Method of Treatment
6.1 Introduction
6.1.1 Sterilization
6.1.3 Chemical
6.1.4 Radiation
7 Global Hospital Acquired Infections Market, by Infection Type
7.1 Introduction
7.1.1 Urinary Tract Infections
7.1.3 Blood Stream Infections
7.1.4 Surgical Site Infections
7.1.5 Gastrointestinal Infections
7.1.6 Respiratory infections
8 Global Hospital Acquired Infections Market, by Regions
8.1 Introduction
8.1.1 Americas
8.1.1.1 North America
8.1.1.2 South America
8.1.2 Europe
8.1.2.1 Germany
8.1.2.2 France
8.1.2.3 UK
8.1.2.4 Italy
8.1.2.5 Spain
8.1.2.6 Rest of Europe
8.1.3 Asia Pacific
8.1.3.1 Japan
8.1.3.2 China
8.1.3.3 India
8.1.3.4 Republic of Korea
8.1.3.5 Rest of Asia Pacific
8.1.4 Middle East & Africa
9 Company Landscape
9.1 Introduction
9.1.1 Mergers Acquisitions
9.1.2 Collaborations
9.1.3 Release/New Product Launches
9.1.4 Other (Expansion, Updates, Partnership)
10 Company Profile
10.1 Advanced Sterilization Products
10.1.1 Company Overview
10.1.2 Product/Business Segment Overview
10.1.3 Financials
10.1.4 Key Developments
10.1.5 SWOT Analysis
10.2 3M Company
10.2.1 Overview
10.2.2 Product/Business Segment Overview
10.2.3 Financials
10.2.4 Key Developments
10.2.5 SWOT Analysis
10.3 Becton Dickinson and company
10.3.1 Overview
10.3.2 Product/Business Segment Overview
10.3.3 Financials
10.3.4 Key Developments
10.3.5 SWOT Analysis
10.4 STERIS Corporation
10.4.1 Overview
10.4.2 Product/Business Segment Overview
10.4.3 Financials
10.4.4 Key Developments
10.4.5 SWOT Analysis
10.5 Getinge AB
10.5.1 Overview
10.5.2 Product/Business Segment Overview
10.5.3 Financials
10.5.4 Key Developments
10.5.5 SWOT Analysis
10.6 Cantel Medical Corp.
10.6.1 Overview
10.6.2 Product/Business Segment Overview
10.6.3 Financials
10.6.4 Key Developments
10.6.5 SWOT Analysis
10.7 Belimed AG
10.7.1 Overview
10.7.2 Product/Business Segment Overview
10.7.3 Financials
10.7.4 Key Developments
10.7.5 SWOT Analysis
10.7.6 Others
11 Appendix
List of Tables
TABLE 1 GLOBAL HOSPITAL ACQUIRED INFECTIONS MARKET, 2023-2030 (USD MILLION)
TABLE 2 GLOBAL HOSPITAL ACQUIRED INFECTIONS MARKET, BY PATHOGEN TYPE, 2023-2030 (USD MILLION)
TABLE 3 GLOBAL HOSPITAL ACQUIRED INFECTIONS MARKET, BY METHOD OF TREATMENT, 2023-2030 (USD MILLION)
TABLE 4 GLOBAL HOSPITAL ACQUIRED INFECTIONS MARKET, BY INFECTION TYPE, 2023-2030 (USD MILLION)
TABLE 5 GLOBAL HOSPITAL ACQUIRED INFECTIONS MARKET, BY REGION, 2023-2030 (USD MILLION)
List of Figures
FIGURE 1 RESEARCH PROCESS
FIGURE 2 PORTERS FIVE FORCES MODEL
FIGURE 3 GLOBAL HOSPITAL ACQUIRED INFECTIONS MARKET, BY PATHOGEN TYPE
FIGURE 4 GLOBAL HOSPITAL ACQUIRED INFECTIONS MARKET, BY METHOD OF TREATMENT
FIGURE 5 GLOBAL HOSPITAL ACQUIRED INFECTIONS MARKET, BY INFECTION TYPE
FIGURE 6 GLOBAL HOSPITAL ACQUIRED INFECTIONS MARKET, BY REGION
FIGURE 7 GLOBAL HOSPITAL ACQUIRED INFECTIONS MARKET: COMPANY SHARE ANALYSIS, 2020 (%)
